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Abstract
Thymic CD4+CD25+ cells play an important role in immune regulation and are continuously developed in the thymus as an
independent lineage. How these cells are generated, what are their multiple pathways of suppressive activity and which are
their specific markers are questions that remain unanswered. To identify molecules involved in the function and
development of human CD4+CD25+ T regulatory cells we targeted thymic CD4+CD25+ cells by peptide phage display. A
phage library containing random peptides was screened ex vivo for binding to human thymic CD4+CD25+ T cells. After four
rounds of selection on CD4+CD25+ enriched populations of thymocytes, we sequenced several phage displayed peptides
and selected one with identity to the Vitamin D Receptor (VDR). We confirmed the binding of the VDR phage to active
Vitamin D in vitro, as well as the higher expression of VDR in CD4+CD25+ cells. We suggest that differential expression of
VDR on natural Tregs may be related to the relevance of Vitamin D in function and ontogeny of these cells.
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Introduction
The cells exiting the thymus with the CD4+CD25+ phenotype
are known as natural regulatory T cells (Treg) and develop as a
continuous and independent lineage in this organ [1], [2]. Thymic
development of natural Treg involves the participation of
interleukin (IL) -2, CD28, CTLA-4 (cytotoxic T-lymphocyte
antigen-4, CD152), and transforming growth factor beta (TGFb),
as well as the expression of the transcription factor Foxp3
(forkhead box P3) [3]. Several other molecules, however, may also
play relevant roles.
Natural Tregs actively maintain immunological self-tolerance
and control inflammatory immune responses on both antigen
presenting cells (APC) [4] and effector T cells [5]. Suppression by
regulatory T cells was first shown by the finding that depletion of
CD4+CD25+T cells from wild-type mice led to the spontaneous
development of several autoimmune diseases, such as autoimmune
gastritis, thyroiditis and type 1 diabetes, as well as inflammatory
bowel disease [6]. The same group also observed that reconsti-
tution of these animals with CD4+CD25+T cells prevented the
development of these diseases. Other groups have shown the
importance of natural Tregs in several pathological contexts [7,8].
Natural Tregs are characterized by the constitutive expression
of markers that include the glucocorticoid-induced TNF receptor
family–related protein (GITR), OX40 (CD134), CD27 and
CTLA-4, CD62-L, and membrane TGFb [9] [10]. In addition,
the transcription factor Foxp3, a critical component of Treg
function, can be used to identify these populations [11]. However,
all of these markers can also be detected in induced Treg types
including T regulatory type 1 (Tr1) [12] and T helper type 3 cells
(Th3) [13]. Moreover, non-regulatory T cells can express several
of these proteins, and activated human T cells transiently express
Foxp3 [14]. Therefore, it is currently not possible to identify and
isolate Tregs by a single specific marker. More recently, a
transcription factor from the Ikaros family, Helios, was reported to
be selectively expressed on natural Tregs and not in induced
Tregs, in both mice and humans [15].
Despite the variety of immune active molecules on natural
Tregs, indicative of the diversity of mechanisms involved in their
suppressive activity, it is likely that several other pathways
participate in both the development and function of Tregs. To
identify other proteins involved in the function and development
of human CD4+CD25+ T regulatory cells, we targeted thymic
CD4+CD25+ cells with a peptide phage-display library, using a
technology that has allowed the identification of relevant
functional molecules in other contexts. Using this approach, we
identified a phage-displayed peptide with sequence similarity to
the Vitamin D Receptor (VDR) that specifically bound active
Vitamin D in vitro. We also showed that CD4+CD25+ express
higher levels of VDR than CD252 counterparts, which probably
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e21702leads to higher binding and signaling by Vitamin D in the first
cells. These data support a role for Vitamin D in the development
and/or function of CD4+CD25+ human thymocytes.
Materials and Methods
Study subjects
Thymic specimens were obtained from children who underwent
corrective cardiac surgery at Heart Institute of Sa ˜o Paulo, Brazil.
Thymuses were removed only under medical indication, and the
children’s parents signed the Informed Consent authorizing the
use of thymic tissue, which otherwise would have been discarded.
The underlying diseases were all congenic; no child had
autoimmune diseases. The children’s ages ranged from 15 days
to 8 years old; 1 was female and 3 were male. This study was
approved by the Hospital das Clı ´nicas HCFMUSP Ethical
Committee (CAPPesq 404/03).
Isolation of CD4+ thymocytes and sorting of CD4+CD25+
cells
Human thymic specimens were used as sources of CD4+CD25+
thymocytes. To obtain CD4+ thymocytes we first performed
negative selection of CD8+ and double-positive (DP) thymocytes
by magnetic cell sorting (MACS - Mylteni Biotec, Germany), as
described by the manufacturer. Briefly, thymic mononuclear cell
(MNC) suspensions were incubated for 20 min with a mixture of
anti-CD14, anti-CD16, anti-CD19, anti-CD34, anti-CD56, anti-
glycophorin A, B and anti-CD8 monoclonal antibodies (mAbs),
extensively washed, and subsequently incubated for additional
20 min with goat anti-mouse polyclonal Ab conjugated to colloidal
super-paramagnetic microbeads, as described in the MACS
system protocol. Washed cells were separated on a medium-sized
magnetic column (MS+). The purified whole CD4+ thymocyte
enriched population was used for the sorting of CD4+CD25+ and
CD4+CD252 cells in a high pressure FACSAria cell sorter (BD
Biosciences – Mountain View, CA).
Phage screening
We used a random peptide library comprised of CX7C (C,
cysteine; X, any amino acid), which was introduced into the
fUSE5 vetor digested with Sfi restriction enzyme. X residues are
encoded by NNK. The library had a diversity of approximately
2610
8 peptides [16]. Screening of the phage library was
performed by the BRASIL method [17], which allows the
separation of cell-bound from unbound phage in one step.
CD4+CD252 cells were used for preclearing and CD4+CD25+
thymocytes were used for biopanning and selection of bound
phage.
The cell suspension was incubated with the phage library (10
9
Transducing units, TU) at 4uC for 2 h. Unbound phages were
removed by centrifugation into the oil phase whereas bound
phages were recovered from the cell pellet and rescued by addition
of K91 host bacteria. The phage output was determined by
counting of the number of colonies on agar plates. The eluted
phages were propagated in bacterial cells and were used for the
next round of selection. After four rounds, individual clones were
randomly picked and cryopreserved.
Thymocytes negative for CD25 were initially incubated with the
phage library for a subtractive screening; phage clones that did not
bind to CD252 cells were further incubated with CD4+CD25+
thymocytes. Four rounds of these negative and positive selections
were performed using the BRASIL method, as described above.
From each round, the bound phage were retrieved and amplified
in K91 E. coli for use in the subsequent round of panning.
The DNA inserts of selected phage clones were sequenced on an
automatic sequencer (Applied Biosistems). The translated peptide
sequences were aligned using Clustal W program (www.expasy.ch)
and analyzed with the NCBI BLAST (http://www.ncbi.nlm.nih.
gov) to identify proteins with similar motifs.
Binding assays of phage clones to cells
Thymocytes were separated using a FACSAria and were
ressuspended in Dubelcco Modified Elementary Media (DMEM)
containing 1% bovine serum albumin (BSA). The cell suspension
was incubated with the amplified target phage or with a control
phage having no inserted peptide (Fd phage) and the mixture was
kept on ice for 4 h. Cells were again separated by centrifugation
through an organic oil phase, and bound phages were recovered
by bacterial infection and quantified by colony count.
Binding assays of phage clones to proteins using ELISA
1,25-dihydroxy vitamin D3 (1 mM) (from now on called
Vitamin D), vitamin D receptor (VDR) (200 uM) (Fluka
Biochemika, St. Gallen, Switzerland) or BSA (3% in Phophate
Buffer Solution- PBS) were immobilized overnight on high-bind
96 TM-well plates (Pierce/Thermo Fisher- Waltham, MA) at 4uC.
The wells were washed twice with PBS, blocked with PBS
containing 3% BSA at room temperature for 2 h, and incubated
with 1610
9 TU of VDR phage, negative control Fd phage or
VDR phage, previously incubated with Vitamin D in 50 ml of PBS
containing 1.5% BSA. After 1 h at room temperature, wells were
washed 9 times with PBS, and phage binding was measured by
enzyme-linked immuno sorbent assay (ELISA). Results were
calculated subtracting the OD from phage bound to BSA.
Flow cytometry analysis
Intracellular expression of both VDR and Foxp3 was evaluated
in thymocytes by flow cytometry (FACSCanto, BD Biosciences,
Palo Alto, CA), and analyzed using FlowJo (TreeStar Inc). Cells
were stained by anti-CD4PerCP or anti-CD4FITC, anti-
CD25APC or anti-CD25PE and anti-CD8 Texas Red, then fixed
and permeabilized before staining with anti-Foxp3PE and anti-
VDR followed by secondary anti –antibody APC-labeled. All
mAbs were purchased from BD Biosciences except anti-Foxp3 and
secondary APC, provided by eBioscience and anti-VDR, provided
by Affinity Bioreagents.
Statistical analysis
All samples from the three ELISA binding assays were analyzed
using Kolmogorov-Smirnov and D’Agostino-Pearson normality
tests, and both indicated non-parametric distribution. Kruskal
Wallis was then used to compare data from the four independent
groups, obtained after subtraction of BSA binding ODs.
Significant statistical difference was considered when p,0.05.
Results
CD4+CD25+ thymic cell isolation
In order to separate CD4+CD25+ from CD4+CD252
thymocytes we performed cell sorting by high-pressure flow
cytometry in a FACSAria sorter. Different numbers of thymocytes
were used for the 4 rounds of selection with the phage library. The
gate strategy for the sorting of CD4+CD25+ cells is shown in
figure S1. The following enrichment of CD4+CD25+ cells was
achieved: 44.4% (2610
6 cells), 57.3% (9.7610
5 cells), 39.5%
(1.4610
6 cells), and 72.7% (5.4610
6 cells), respectively, for rounds
1 to 4. Despite the relatively low purity of the selected CD4CD25+
population, the strategy of pre-clearing (subtraction) in a 90% pure
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bound preferentially to CD25+ cells.
Selection of phage-binding CD4+CD25+ thymic cells
The phage clones that did not bind to the CD25 negative cells
were incubated with the CD4+CD25+ thymocytes to select phages
that bind specifically to the CD25 positive population. The
number of phages recovered from the second incubation with
CD4+CD25+ cells increased 1.5 fold over the number of phages
recovered from round 1 (Figure 1 and Table 1). The output-input
ratio of phage after each round of panning was used to determine
the efficiency of phage recovery [18]. We observed a 3-fold
enrichment from the first to the third round (output/input from 6
to 18610
26). In the fourth round, in which we used the most
enriched CD4+CD25+ population for panning, the enrichment
decreased compared to third round (Table 1), probably indicating
a more stringent selection compared to the other rounds.
Candidate phage displays similarity to the Vitamin D
Receptor
After 4 rounds of panning of CD4+CD25+ thymocytes with the
phage library, approximately 700 clones were picked and
cryopreserved and 28 phages were chosen at random. The
peptide-coding DNA inserts of the 28 phage clones were amplified
by PCR and sequenced. Alignment of peptide sequences using
Clustal W program revealed no repeated sequences among the
selected phages (Table 2). A list of the selected phage peptides and
their corresponding human proteins is presented in Table 2.
Among the identified bound phage peptides we found proteins
known to be Treg markers, such as LAP, GITR, IL12p25
(subdomain of IL35, a Treg hallmark cytokine), which validates
our approach.
The Vitamin D receptor phage (VDR phage) peptide showed
similarity to the Vitamin D3 receptor. Five amino acids (aa)
exhibited total identity with the VDR sequence and two aa were
conservative substitutions. In Figure 2 we show the vitamin D hit
obtained following BLAST analysis. To identify the region of the
VDR that matches the VDR phage, we aligned the full-length
protein sequence of the VDR with the phage peptide (Figure 3).
The VDR phage peptide aligned with the region of the VDR that
interacts with the Vitamin D ligand (aa 239–246).
Using the RasMol program (http://www.ncbi.nlm.nih.gov), we
assessed the 3D-structure of the VDR complexed to Vitamin D.
The structural model of the receptor revealed that the phage
peptide region is located in one of the alpha helices that compose
the ligand binding domain. The position of the VDR phage
peptide within the structure of the VDR is shown in Figure 4.
VDR phage binds to CD4+CD25+ thymocytes and to
immobilized active Vitamin D3
To analyze the binding specificity of VDR phage to
CD4+CD25+ thymocytes we performed a comparative binding
assay with CD4+CD25+ as well as CD4+CD252 cells. A higher
binding of the VDR phage to CD4+CD25+ cells was observed in
this experiment, as shown in Figure 5.
To validate the ligation of the VDR phage to Vitamin D, an
ELISA assay was performed with immobilized Vitamin D or
VDR. The targeted VDR phage bound more to active Vitamin D
than an ‘‘insertless’’ control phage (Fd phage, Figure 6), indicating
that VDR peptide is responsible for binding to Vitamin D.
Preincubation of VDR phage with Vitamin D prevented the
ligation of Vitamin D to its active receptor, confirming that the
peptide corresponds to Vitamin D binding pocket of VDR
molecule.
Higher VDR expression in CD4+CD25+ thymocytes and in
Foxp3+ thymocytes
To verify whether the enhanced binding of the VDR phage to
CD4+CD25+ cells in comparison to CD4+CD252 cells was
related to a higher expression of VDR in CD25 positive cells, we
analyzed the expression of the VDR in thymocytes by FACS using
a VDR specific antibody. VDR expression was 2.5 fold higher in
CD4+CD25+ thymocytes than in CD4+CD252 cells (Figure 7),
despite being expressed in all thymic cells.
We also analyzed the relation between VDR expression and
Foxp3 expression in thymic cells. Again, VDR expression was
almost 3 fold higher (2.79 fold) in Foxp3+ CD4+CD25+
thymocytes (Figure 8). All CD25 positive cells in the thymus
expressed Foxp3: double negative, double positive, and CD4 or
CD8 single cells (Figure S2).
Discussion
Our aim in this work was to search for proteins expressed on
human CD4+CD25+ thymic cells that were potentially relevant to
the function and development of natural regulatory T cells.
Phage display technology has been used to identify peptide
ligands in different systems and in a variety of cell types in vitro
and in vivo [19]. Although antibody phage display has been useful
for the identification of molecules involved in homing to the
Figure 1. Specific enrichment of CD4+CD25+ cell–bound
phages. The titer of phages recovered from each round was evaluated
by a plaque-forming assay. R1–R4, 1st–4th round of panning in vitro.
Cfu: colony forming units.
doi:10.1371/journal.pone.0021702.g001
Table 1. Output/input values for thymic CD4+CD25+
selection.
Round of Panning Input Number Output Number Ratio
15 610‘93 610‘46 610‘-6
25 610‘95 610‘41 0 610‘-6
35 610‘99 610‘41 8 610‘6
45 610‘92 610‘44 610‘6
The ratio was calculated as output number/input number of phages (cfu).
cfu: colony forming units.
doi:10.1371/journal.pone.0021702.t001
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could be appropriate for the study of new markers in natural
Tregs.
In this study we used phage display to define binding sites on
nTregs. The phage peptides that bound to Tregs might be
exploited as a means to expand current knowledge of nTreg
interactions during the development of this subtype of T cells.
Besides, once these sites are clearly identified, the peptides may be
used to study molecules which could improve or block the
regulatory activity.
Using a peptide phage display library in a screening protocol
that included subtraction and positive selection on intact viable
thymocytes, we identified peptides that preferentially bound to
CD4+CD25+ cells. The optimizing procedures with several
rounds of panning improved the probability of obtaining phages
that preferentially bound to target cells. In fact, in most cases we
observed an increase in the output/input ratio during the
successive rounds (Figure 1). However, those data should be
analyzed considering the CD4+CD25+ thymocyte purity during
each step. In the first three rounds, we observed a progressive
enrichment of output phages (3 fold increase), while a decrease was
seen from the third to the fourth step. This decrease can be
attributed to a selection using a specially enriched CD4+CD25
population in the fourth round (72% compared to 39 to 53% in
the other rounds). Consequently, phages selected in the first three
rounds may include those that bound to CD4+CD25+ and some
that bound to CD252 cells, while phages recovered from the
fourth round would be preferentially directed to our target
CD4+CD25+ population. Besides, the negative selection of phages
(pre-clearing) using a 90% pure CD4+CD252 population
Table 2. Selected peptide sequences and the corresponding human proteins containing the homologous motif.
Peptide Motif Protein Accesion Number
CLLGTRWPC LLGARWFPKTLPC toll-like receptor 7 [Homo sapiens] gi|76780835
CFMESVGRC FMEGVG leptin receptor [Homo sapiens] gi|1589772
CLTPEFHIC CVTPEYHCGDPQCKIC tumor necrosis factor receptor superfamily member 18 isoforma 2 (GITR-D, GITR-C e GITR-B)
(Homo sapiens)
gi|23238194
CLAVGEVLC LAVAECLC interleukin 17C [Mus musculus] gi|22003880
CFVSPPVGC CFCSPP Latent transforming growth factor beta-binding protein 2 gi|62089316
CMPGWEVLC PGWEV IL-13p600 [Homo sapiens] gi|19070472
CKRGNSGSC NSGSC semaphorin 5B isoform 2 [Homo sapiens] gi|72534694
CQRLVGFAC CQRLVG—FA thyroid hormone receptor-associated protein complex component TRAP240 [Homo sapiens] gi|4530437
CQRLMTF Toll-like receptor 6 [Mus musculus] gi|33286898
QKVVGFA vitamin D receptor [Homo sapiens] gi|4262865
CLQASPNFC CIQAGPN Integrin (CD29) [Homo sapiens]
CLQSSGNF E-selectin (ELAM-1) [Homo sapiens] gi|462500
CNGSVRSFC NGSCRDFC defensin, beta 108B [Homo sapiens] gi|50344744
GSVGSFC transforming growth factor, beta 2 [Rattus norvegicus] gi|13592109
CPGFGLAYC GFGLPY latent TGF-beta binding protein-4 [Homo sapiens] gi|2190402
GFGLAF interleukin 20 [Mus musculus] gi|84627505
PGFGL interleukin 12 p35 subunit [Sus scrofa] gi|47522812
CFLFTFEAC CFLFT similar to 60 kDa heat shock protein, mitochondrial precursor (Hsp60) [Bos taurus] gi|76648520
CRGVLMRYC MRYC semaphorin 5A [Homo sapiens] gi|4506881
CRAFVVASC CRSFAVAIC C9 complement protein[Homo sapiens] gi|6706618
CQSHSAFVC SAFSC interleukin-21 [Homo sapiens] gi|11141875
Peptides were analyzed with the NCBI BLAST search against the SWISSPROT database, with the option for short nearly exact matches.
doi:10.1371/journal.pone.0021702.t002
Figure 2. BLAST hit for VDR phage. Length: of the Vitamin D Receptor; Score: punctuation score given for the alignment; Expected: e-value;
Identities: number of identical amino acids between queried sequence and the corresponding amino acid sequence of the VDR protein; Positives:
number of amino acids that align to the VDR protein; Gaps: spaces between amino acids that do not match; Query: VDR phage peptide sequence;
Sbjct: fragment of the VDR that matches to the phage sequence. The numbers indicate the position of the amino acids in the phage peptide and in
the VDR protein.
doi:10.1371/journal.pone.0021702.g002
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populations used for positive selection (panning).
Among the phages sequenced we selected a specific phage
peptide for further analysis due to its sequence similarity to the
Vitamin D receptor (VDR). This was our first choice because
although Vitamin D has been extensively reported to display
immunoregulatory functions in different contexts [21], its role has
not been well-defined for human thymic T regs, opening an
interesting area for research.
We hypothesized that the ligand recognized by the VDR
phage was Vitamin D complexed to its receptor on
CD4+CD25+ thymocytes, because the sequence represented
by the phage peptide is located in the VDR region that interacts
with the Vitamin D ligand (aa 239–246) and the structural
model of the receptor revealed that the phage peptide region is
located in one of the alpha helices that compose the ligand
binding domain (LBD). The results from the ELISA assay
showing that VDR phage was able to bind to active Vitamin D
strongly supports our hypothesis. When phages were preincu-
bated with Vitamin D we did not observe binding to VDR,
confirming that the peptide, in fact, mimic the Vitamin D
binding pocket in VDR (Figure 2) and is able to prevent
Vitamin D from binding to its native receptor.
We do not know whether the identified peptide is an
oligomerization domain. However, it is known that upon
activation by vitamin D, VDR usually forms a heterodimer with
the retinoid-X receptor and binds to hormone response elements
on DNA, resulting in the expression or transrepression of specific
gene products. It has also been reported that a predominant C-
terminal heterodimerization domain resides between residues
382–403 in VDR sequence, about 137 aa distant from our
VDR-phage. It was shown that mutations inserted in this region of
the VDR sequence (Lys 382, Met-383 or Glu-385) completely
disrupted the associations of VDR-RXR and VDR with other
partners, and eliminated the transcriptional activity of VDR [22],
indicating the importance of this region to heterodimerization.
Other partners can also physiologically dimerize with VDR such
as Mediator of RNA polymerase II (MED1 and MED12) [23],
nuclear receptor co-repressor (NCOR1) [24] and nuclear receptor
co-activator (NCOA2) [25], co-activators or co-repressors that
direct transcriptional initiation by the RNA polymerase II
apparatus [26].Thus, although the 382–403aa domain in VDR
Figure 3. ClustaW alignment of the VDR phage peptide sequence and the human VDR full-length protein sequence.
doi:10.1371/journal.pone.0021702.g003
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exclude the existence of other domains too.
The higher expression of VDR observed in CD25+ compared
to CD252 cells (Figure 7), if associated with a corresponding
higher binding of Vitamin D to VDR in these cells, supports our
isolation of VDR phage after panning in CD4+CD25+ thymo-
cytes. Another important observation was the positive relation
between Foxp3 expression and VDR expression in thymic cells
(Figure 8). Studies using mice in a Trinitrobenzene Sulfonic Acid
(TSA) induced colitis model, treated with Vitamin D and
dexamethasone, show that the combined use of Vitamin D and
dexamethasone enhanced Foxp3 expression accompanied by the
induction of IL-10 and TGF-beta [27]. However, in vitro-
generated homogenous populations of IL-10 Tregs obtained by
stimulating naive CD4 T cells in the presence of the anti-
inflammatory drugs Vitamin D and dexamethasone did not
express high levels of Foxp3 [28]. Thus, although Foxp3 appears
to be important for the development and function of naturally
occurring CD4+CD25+ T cells, in vitro derived IL-10-secreting
Tregs appear to have regulatory functions despite low levels of
Foxp3.
Here, we report a high expression of VDR in thymic
CD25+Foxp3+ suggesting that VDR may, indeed, be involved
in the natural regulatory T cell lineage development in the thymus.
Interestingly, molecules known to dimerize with VDR such as
retinoic X receptor (RXR) have been shown to physically interact
with Foxp3 [29]. The complexed VDR can dimerize with Vitamin
A receptors (the retinoic acid receptor and the retinoic X receptor)
and bind to Vitamin D response elements (VDrEs) in the
promoters of Vitamin D-responsive genes [30]. Given that
Vitamin A has roles in immunoregulation that include the
generation of induced Tregs [31,32,33], we hypothesize that
Vitamins D and A might act synergistically in immunoregulatory
pathways and possibly on natural Tregs.
An interesting question is whether the VDR phage ligand on
CD4+CD25+ thymocytes is located intracellularly or on the cell
surface. Although it is generally accepted that peptides presented
by phage particles bind to surface molecules, investigators have
reported that some phage can reach intracellular compartments by
an yet unknown mechanism [9]. Taking into consideration that
phage can be readily internalized by cells [34,35], it is thus possible
that the VDR phage binds directly to Vitamin D inside the cell.
We did observe higher VDR intracellular expression in
Figure 4. Structural model of the Vitamin D Receptor
associated with its ligand (Vitamin D). Green: alpha helical
sequences; gold: beta sheet; blue: structural handle, yellow: phage
peptide.
doi:10.1371/journal.pone.0021702.g004
Figure 5. Binding assay with thymic CD4+CD25+ cells and
CD4+CD252 cells. Fd: wild type phage bearing no inserted peptide
sequence; TU: transforming units.
doi:10.1371/journal.pone.0021702.g005
Figure 6. ELISA to evaluate the binding of the VDR phage to
plate-bound Vitamin D or VDR. Fd shows the binding of the control
phage to plate-bound Vitamin D; VDRpVit shows the binding of the
VDR phage to plate-bound Vitamin D; VDRpVDR shows the binding of
the VDR phage to plate-bound VDR; VDRpVitVDR shows binding of the
VDR phage pre-incubated with Vitamin D to plate-bound VDR.
*** p=0.001.
doi:10.1371/journal.pone.0021702.g006
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(Figure 7), but we were unable to detect VDR cell surface
expression using the same commercial anti-VDR antibody (data
not shown). We cannot be sure, however, that the anti-VDR
antibody we used in our study is appropriate for cell surface
expression. Nevertheless, the VDR could also (or alternatively) be
expressed at the cell surface, as suggested by others [36,37,38].
Taken together, our results favor that Vitamin D has functions
in natural Treg activity or ontogeny. Although the role of Vitamin
D in natural Tregs immunobiology needs to be better defined,
data from several groups showing its immunoregulatory activity on
different cells [39] reinforce the idea that similar functions may
also be relevant for natural Tregs. The immunoregulatory role of
Vitamin D has been studied in the induction of tolerogenic
dendritic cells with the production of IL-10 and TGF-beta [40,41]
and in the generation of induced Tregs [42]. However, in the
majority of studies on T cells, Vitamin D was used in combination
with other molecules, such as dexamethasone [43] and IL-2 [44].
More recently, Vitamin D has been reported to induce and/or
increase the expression of Foxp3 and CTLA-4 in purified
CD4+CD252 human T cells [44]. It was also suggested that
Vitamin D interacts with Vitamin D Responsive Elements
(VDRE) in the Foxp3 gene and enhances Foxp3 expression in
CD4+ cells [29]. Other data that support an immunoregulatory
role for Vitamin D are derived from animal models of
autoimmune diseases, in which the use of Vitamin D partially
suppresses the development of experimental autoimmune enceph-
alomyelitis, inflammatory bowel disease, and diabetes [45,46,47].
The mechanisms by which Vitamin D reduces the inflammatory
process in these contexts remain unclear.
In summary, our data support the notion of an immunoregu-
latory role for Vitamin D in natural Tregs and a functional
Figure 7. FACS analysis of VDR expression in CD25+ and CD252 cells in the CD4+ cell compartment. A: Dot plot showing thymocytes
region; B: Dot plot showing the CD4+ gated cells; C: Dot plot showing percentage of CD25positive and negative cells in the CD4+ region;
D: Histogram showing the expression of VDR in CD4+CD25+ (blue) and CD4+CD252(red) thymocytes; E: Table showing MFI (median fluorescence
intensity) of the intracellular VDR labeling of the cells.
doi:10.1371/journal.pone.0021702.g007
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these cells in the thymus. This observation may shed light on
possible interventional strategies for Tregs, contributing to this
ongoing rich research field.
Supporting Information
Figure S1 FACS Dot Plot graph showing the percentage
of Foxp3 population in thymus. A: Dot Plot showing the
lymphocyte region; B: FACS Dot Plot showing the region of
double positive cells; C FACS Dot Plot showing the region of
double negative cells; D: FACS Dot Plot showing the region of
CD8 single positive cells; E FACS Dot Plot showing the region of
CD4 single positive cells. From B to E: Left: Dot Plot; Central:
Histogram of Foxp3 staining. Right: Table showing MFI (median
fluorescence intensity) of the intracellular Foxp3 labeling of the
cells.
(TIF)
Figure S2 FACS Dot Plot graph showing percentage of
enriched CD4+CD25+ population used for phage peptide
screening. Example from the fourth round of panning. A: Dot
Plot showing the lymphocyte region gated for CD4+ enriched cell
sorting; B: FACS Dot Plot showing the region selected for CD4+
sorting; C and D: FACS Dot Plot showing the percentage of
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